Utility of hyaluronan oligomers and transforming growth factor-beta1 factors for elastic matrix regeneration by aneurysmal rat aortic smooth muscle cells

Tissue Engineering - Part A

Volumn 15, Issue 11, 2009, Pages 3247-3260

  Kothapalli, Chandrasekhar R ^a,b   Gacchina, Carmen E ^a   Ramamurthi, Anand ^a,c  

^a AMRL   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; BLOOD VESSELS; CALCIUM; CALCIUM CHLORIDE; CATALYSTS; CELL PROLIFERATION; COLLAGEN; ENZYME INHIBITION; ENZYMES; GLYCOPROTEINS; MUSCLE; OLIGOMERS; PEPTIDES; SYNTHESIS (CHEMICAL);

AORTIC ANEURYSMS; AORTIC DIAMETER; CELLULAR PROLIFERATIONS; DEGRADING ENZYMES; ELASTASE; ELASTIC FIBER; ELASTIC MATRIX; ELASTIN MATRIX; HYALURONAN; LYSYL OXIDASE; MATRIX; MATRIX FORMATION; MATRIX METALLOPROTEINASES; ORDER OF MAGNITUDE; POTENTIAL UTILITY; PROTEIN SYNTHESIS; RAT AORTIC SMOOTH MUSCLE CELLS; SMOOTH MUSCLE CELLS; TRANSFORMING GROWTH FACTORS; TROPOELASTIN; VASCULAR CELLS; VESSEL RUPTURE;

CELL CULTURE;

CALCIUM CHLORIDE; COLLAGEN; DESMOSINE; ELASTASE; ELASTIN; FIBRILLIN; GELATINASE A; GELATINASE B; HYALURONIC ACID; OLIGOMER; PROTEIN LYSINE 6 OXIDASE; TRANSFORMING GROWTH FACTOR BETA1; TROPOELASTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ANEURYSM; ARTICLE; CALCIFICATION; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CROSS LINKING; DISEASE COURSE; ELASTIC FIBER; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNODETECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SMOOTH MUSCLE FIBER;

RATTUS;

EID: 72649103258     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0593     Document Type: Article

References (53)

1. Selle, J.G., Robicsek, F., Daugherty, H.K., and Cook, J.W. Thoracoabdominal aortic aneurysms. A review and current status. Ann Surg 189, 158, 1979.
2. Milewicz, D.M., Dietz, H.C., and Miller, D.C. Treatment of aortic disease in patients with Marfan syndrome. Circulation 111, e150, 2005.
3. Daugherty, A., and Cassis, L.A. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 24, 429, 2004.
4. Rentschler, M., and Baxter, B.T. Pharmacological approaches to prevent abdominal aortic aneurysm enlargement and rupture. Ann NY Acad Sci 1085, 39, 2006.
5. Mecham, R.P., Broekelmann, T.J., Fliszar, C.J., Shapiro, S.D., Welgus, H.G., and Senior, R.M. Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis. J Biol Chem 272, 18071, 1997.
6. Petersen, E., Gineitis, A., Wagberg, F., and Angquist, K.A. Activity of matrix metalloproteinase-2 and-9 in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 20, 457, 2000.
7. Lindholt, J.S., Jorgensen, B., Klitgaard, N.A., and Hennererg, E.W. Systemic levels of cotinine and elastase, but not pulmonary function, are associated with the progression of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 26, 418, 2003.
8. Guo, D.C., Papke, C.L., He, R., and Milewicz, D.M. Patho-genesis of thoracic and abdominal aortic aneurysms. Review. Ann NY Acad Sci 1085, 339, 2006.
9. Ernst, C.B. Abdominal aortic aneurysms. N Engl J Med 328, 1167, 1993.
10. Isselbacher, E.M. Thoracic and abdominal aortic aneurysms. Circulation 111, 816, 2005.
11. Galis, Z.S., and Khatri, J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90, 251, 2002.
12. Keeling, W.B., Armstrong, P.A., Stone, P.A., Bandyk, D.F., and Shames, M.L. An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic an-eurysms. Vasc Endovasc Surg 39, 457, 2005.
13. Isenburg, J.C., Simionescu, D.T., Starcher, B.C., and Vyava-hare, N.R. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation 115, 1729, 2007.
14. Isenburg, J.C., Karamchandani, N.V., Simionescu, D.T., and Vyavahare, N.R. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials 27, 3645, 2006.
15. Allaire, E., Muscatelli-Groux, B., Guinault, A.M., Pages, C., Goussard, A., Mandet, C., Bruneval, P., Méllière, D., and Becquemin, J.P. Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis. Ann Surg 239, 417, 2004.
16. Joddar, B., and Ramamurthi, A. Fragment size-and dose-specific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells. Biomaterials 27, 2994, 2006.
17. Joddar, B., and Ramamurthi, A. Elastogenic effects of exogenous hyaluronan oligosaccharides on vascular smooth muscle cells. Biomaterials 27, 5698, 2006.
18. Kothapalli, C.R., Taylor, P.M., Smolenski, R.T., Yacoub, M.H., and Ramamurthi, A. TGF-b1 and hyaluronan oligomers syn-ergistically enhance elastin matrix regeneration by vascular smooth muscle cells. Tissue Eng 15, 501, 2009.
19. Kothapalli, C.R., and Ramamurthi, A. Benefits of concurrent delivery of hyaluronan and IGF-1 factors to regeneration of crosslinked elastin matrices by adult rat vascular cells. J Tissue Eng Regen Med 2, 106, 2008.
20. Wight, T.N. Versican: a versatile extracellular matrix pro-teoglycan in cell biology. Curr Opin Cell Biol 14, 617, 2002.
21. Davidson, J.M., Zoia, O., and Liu, J.M. Modulation of transforming growth factor-beta 1 stimulated elastin and collagen production and proliferation in porcine vascular smooth muscle cells and skin fibroblasts by basic fibroblast growth factor, transforming growth factor-alpha, and insulinlike growth factor-I. J Cell Physiol 155, 149, 1993.
22. Shanley, C.J., Gharaee-Kermani, M., Sarkar, R., Welling, T.H., Kriegel, A., Ford, J.W., Stanley, J.C., and Phan, S.H. Transforming growth factor-beta 1 increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells. J Vasc Surg 25, 446, 1997.
23. Basalyga, D.M., Simionescu, D.T., Xiong, W., Baxter, B.T., Starcher, B.C., and Vyavahare, N.R. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation 110, 3480, 2004.
24. Chiou, A.C., Chiu, B., and Pearce, W.H. Murine aortic an-eurysm produced by periarterial application of calcium chloride. J Surg Res 99, 371, 2001.
25. Labarca, C., and Paigen, K. A simple, rapid, and sensitive DNA assay. Anal Biochem 102, 344, 1980.
26. Palamakumbura, A.H., and Trackman, P.C. A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal Biochem 300, 245, 2002.
27. Simionescu, A., Philips, K., and Vyavahare, N. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun 334, 524, 2005.
28. Robert, A.M., and Robert, L. Biology and Pathology of Elastic Tissues. Chapters II, III, and IV. Basel, Switzerland: S. Karger, 1980.
29. Swee, M.H., Parks, W.C., and Pierce, R.A. Developmental regulation of elastin production. Expression of tropoelastin pre-mRNA persists after down-regulation of steady-state mRNA levels. J Biol Chem 270, 14899, 1995.
30. Powell, J. Models of arterial aneurysm: for the investigation of pathogenesis and pharmacotherapy-a review. Atherosclerosis 87, 93, 1991.
31. Wills, A., Thompson, M.M., Crowther, M., Brindle, N.P., Nasim, A., Sayers, R.D., and Bell, P.R. Elastase-induced matrix degradation in arterial organ cultures: an in vitro model of aneurysmal disease. J Vasc Surg 24, 667, 1996.
32. Anidjar, S., Salzmann, J.L., Gentric, D., Lagneau, P., Ca-milleri, J.P., and Michel, J.B. Elastase-induced experimental aneurysms in rats. Circulation 82, 973, 1990.
33. Gertz, S.D., Kurgan, A., and Eisenberg, D. Aneurysm of the rabbit common carotid artery induced by periarterial application of calcium chloride in vivo. J Clin Investig 81, 649, 1988.
34. Longo, G.M., Xiong, W., Greiner, T.C., Zhao, Y., Fiotti, N., and Baxter, B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Investig 110, 625, 2002.
35. Kondo, S., Hashimoto, N., Kikuchi, H., Hazama, F., and Kataoka, H. Apoptosis if medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke 29, 181, 1998.
36. Slevin, M., Krupinski, J., Kumar, S., and Gaffney, J. Angio-genic oligosaccharides of hyaluronan induce protein tyro-sine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Investig 78, 987, 1998.
37. Isogai, Z., Aspberg, A., Keene, D.R., Ono, R.N., Reinhardt, D.P., and Sakai, L.Y. Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J Biol Chem 277, 4565, 2002.
38. Zimmermann, D.R., Dours-Zimmermann, M.T., Schubert, M., and Bruckner-Tuderman, L. Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol 124, 817, 1994.
39. Kähäri, V.M., Olsen, D.R., Rhudy, R.W., Carrillo, P., Chen, Y.Q., and Uitto, J. Transforming growth factor-b up-regulates elastin gene expression in human skin fibroblasts. Evidence for post-transcriptional modulation. Lab Investig 66, 80, 1992.
40. Davidson, J.M., Zang, M.C., Zoia, O., and Giro, M.G. Regulation of elastin synthesis in pathological states. In: The Molecular Biology and Pathology of Elastic Tissues. Eds. Chadwick, D.J., and Goode, J.A. Ciba Foundation Symposium, Wiley Chichester 192, 81, 1995.
41. Massague, J. TGF-beta signal transduction. Annu Rev Bio-chem 67, 753, 1998.
42. Zhang, H., Morisaki, T., Matsunaga, H., Sato, N., Uchiyama, A., Hashizume, K., Nagumo, F., Tadano, J., and Katano, M. Protein-bound polysaccharide PSK inhibits tumor invasive-ness by down-regulation of TGF-beta1 and MMPs. Clin Exp Metastasis 18, 345, 2000.
43. Sukhova, G.K., Wang, B., Libby, P., Pan, J.H., Zhang, Y., Grubb, A., Fang, K., Chapman, H.A., and Shi, G.P. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res 96, 368, 2005.
44. Rydziel, S., Varghese, S., and Canalis, E. Transforming growth factor beta1 inhibits collagenase 3 expression by transcriptional and post-transcriptional mechanisms in os-teoblast cultures. J Cell Physiol 170, 145, 1997.
45. Draude, G., and Lorenz, R.L. TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. Am J Physiol Heart Circ Physiol 278, H1042, 2000.
46. Owens, G.K., Geisterfer, A.A., Yang, Y.W., and Komoriya, A. Transforming growth factor-b induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol 107, 771, 1988.
47. Moses, K.L., Yang, E.Y., and Pietenpol, J.A. TGF-b stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63, 245, 1990.
48. Kielty, C.M. Elastic fibres in health and disease. Expert Rev Mol Med 8, 1, 2006.
49. Fornieri, C., Baccarani-Contri, M., Quaglino, D., Jr., and Pasquali-Ronchetti, I. Lysyl oxidase activity and elastin/ glycosaminoglycan interactions in growing chick and rat aortas. J Cell Biol 105, 1463, 1987.
50. Sato, F., Wachi, H., Ishida, M., Nonaka, R., Onoue, S., Urban, Z., Starcher, B.C., and Seyama, Y. Distinct steps of cross-linking, self-association, and maturation of tropoelastin are necessary for elastic fiber formation. J Mol Biol 369, 841, 2007.
51. Shanley, C.J., Gharaee-Kermani, M., Sarkar, R., Welling, T.H., Kriegel, A., Ford, J.W., Stanley, J.C., and Phan, S.H. Transforming growth factor-beta 1 increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells. J Vasc Surg 25, 446, 1997.
52. Smith-Mungo, L.I., and Kagan, H.M. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol 16, 387, 1998.
53. Gacheru, S.N., Thomas, K.M., Murray, S.A., Csiszar, K., Smith-Mungo, L.I., and Kagan, H.M. Transcriptional and post-transcriptional control of lysyl oxidase expression in vascular smooth muscle cells: effects of TGF-beta 1 and serum deprivation. J Cell Biochem 65, 395, 1997